Rezwan Munshi, MD
Internal Medicine · Cedar Rapids, IANPI 1427510122
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (53.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 80.0% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $7,260, more than ten times the $44 reported in 2022. Among internal medicine clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $107.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Boston Scientific$515
- AstraZeneca$310
- Medtronic$214
- Abiomed$182
- Boehringer Ingelheim$175
- plus $478 from 9 others
What the payments were for
- Grants$5,00053%
- Travel & lodging$1,01711%
- Food & beverage$2,87031%
- Education$4905%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 43 | $7,503 |
| Boston Scientific | 4 | $515 |
| AstraZeneca | 9 | $310 |
| Medtronic | 1 | $214 |
| Abiomed | 6 | $182 |
| Boehringer Ingelheim | 5 | $175 |
| Edwards Lifesciences | 1 | $101 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $98 |
| Bayer | 2 | $79 |
| E.r. Squibb & Sons, L.L.C. | 2 | $58 |
| Merck | 1 | $42 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Lantheus Medical Imaging, Inc. | 1 | $28 |
| Novartis | 1 | $26 |
| Teleflex LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TACTICATH$2,500
- ASSURITY$2,500
- GALLANT$596
- ENSITE PRECISION$587
- ENSITE$276
- AZURE XT DR MRI SURESCAN$214
- Rhythmia Mapping System$174
- Farapulse$134
- EMPOWER Leadless Pacemaker System_CRM$107
- HemoSphere$101
How this compares
$9,377 in reported general payments places this provider in the 95th percentile of 583 internal medicine providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 45 | $36,336 |
| JardianceEmpagliflozin | 21 | $12,701 |
| Metoprolol Succinate | 80 | $1,047 |
| Torsemide | 51 | $919 |
| Atorvastatin Calcium | 45 | $294 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 30 | $229 |
| Spironolactone | 30 | $184 |
| ClopidogrelClopidogrel Bisulfate | 35 | $167 |
| Carvedilol | 23 | $148 |
| Losartan Potassium | 26 | $146 |
| Amiodarone Hcl | 11 | $144 |
| Metoprolol Tartrate | 16 | $120 |
| Nitroglycerin | 12 | $77 |
| Furosemide | 23 | $62 |
| Rosuvastatin Calcium | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $175 | $12,70121 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 internal medicine providers in Iowa.
Other internal medicine in Cedar Rapids
- Ali SaeedCedar Rapids$17K
- Fadi YacoubCedar Rapids$7K
- Susan SchimaCedar Rapids$1K
- Mark JohnsonMason City$223K
- Mark CarlsonSioux City$174K
- Madalyn WalshIowa City$80K
- Alan KricsfeldCouncil Bluffs$49K
- Aziz HammoudIowa City$29K
- Matthew FryzekCouncil Bluffs$28K
- Diana Rabadi MararCouncil Bluffs$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.